What did @gavyncaccese actually say?
The creator walked through a basic peptide reconstitution protocol, listing bacteriostatic water, alcohol swabs, and insulin syringes as the core supplies. He described swabbing the vial tops, drawing "one millivare" of bacteriostatic water, injecting it slowly into the peptide vial, and then refrigerating the result. The video runs under a minute and is framed as a beginner guide, with a disclaimer that "everything in this video is fake" appended to avoid platform removal. It is not fake. It is a real procedure, described with some accuracy and some notable gaps.
Worth naming upfront: the creator uses garbled terminology throughout, saying "millivare" and "millivac" when he means milliliter, and calling bacteriostatic water "backwater." These are not minor stylistic quirks. Precision matters when you are working with concentrated bioactive compounds.
Does the science back this up?
The general protocol is broadly consistent with standard reconstitution practice. Yes, bacteriostatic water is the appropriate diluent for most research peptides because the benzyl alcohol preservative (0.9%) inhibits microbial growth, extending usable shelf life. Yes, alcohol swabbing vial septa before needle entry is standard aseptic technique. The refrigeration step is correct.
Where the science gets complicated is everything the video skips. The United States Pharmacopeia (USP) chapters 797 and 800 govern sterile compounding environments, and home reconstitution does not meet those standards by definition. Research on peptide stability, including work by Fosgerau and Hoffmann (2015, Drug Discovery Today) on peptide therapeutics, makes clear that reconstitution conditions, temperature, light exposure, and diluent concentration all affect peptide integrity. The video treats reconstitution as universally simple, but solubility and stability vary significantly across peptide classes. BPC-157, for instance, has different solubility behavior than GHK-Cu or CJC-1295.
What did they get wrong (or right)?
Credit where it is due: the core sequence, swab, draw water, inject slowly into peptide, refrigerate, is defensible. The slow-release injection technique to avoid mechanical degradation is correct. Foam or aggressive agitation can denature peptide bonds, and this step actually matters.
But the errors are significant. First, the video never specifies a water-to-peptide ratio or addresses concentration calculation. Drawing "one milliliter" into an unknown-dose peptide vial tells the user nothing useful about what dose they are actually drawing when they later pull from that vial. This is a meaningful safety omission. Second, the creator uses insulin syringes throughout without explaining that needle gauge and dead space affect actual volume delivered, a known source of dosing error documented in clinical injection technique literature. Third, there is no mention of mixing by gentle rolling rather than shaking, a point that matters for peptide structural integrity. Fourth, no storage duration guidance is given. Bacteriostatic water extends stability, but most reconstituted peptides degrade meaningfully within 30 days even refrigerated, and faster at warmer temperatures.
What should you actually know?
Reconstitution is a real skill with real consequences. The procedure the creator shows is directionally correct but incomplete in ways that affect both safety and efficacy. If you are reconstituting a peptide, the concentration math is not optional. You need to know how many milligrams are in the vial and how many milliliters of bacteriostatic water you are adding to calculate micrograms per unit on your syringe. Skipping this step means you do not actually know what you are injecting.
Aseptic technique also goes further than one alcohol swab. Single-use syringes are non-negotiable. Reconstituted peptides should be stored at 2-8 degrees Celsius and discarded per the manufacturer or compounding pharmacy guidance, typically within 28-30 days. Light exposure accelerates degradation in several peptide classes. And none of this replaces a conversation with a licensed clinician who can supervise the indication, dose, and monitoring. Peptides accessed outside a regulated telehealth or compounding pharmacy context carry contamination and mislabeling risks that no reconstitution technique can address.